CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy

(2016) Heinz-Peter Schultheiss et al.   Clinical Research in Cardiology

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

(2016) Yigal M. Pinto et al.   EUROPEAN HEART JOURNAL

Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection

(2015) Panpan Hou et al.   Scientific Reports

G6PD A- Deficiency and Severe Malaria in The Gambia: Heterozygote Advantage and Possible Homozygote Disadvantage

(2014) Giorgio Sirugo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

CCR5del32 polymorphism is a protective factor in non-ischemic cardiomyopathy

(2014) Dirk Lassner et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Innate Immune Interleukin-1 Receptor–Associated Kinase 4 Exacerbates Viral Myocarditis by Reducing CCR5 + CD11b + Monocyte Migration and Impairing Interferon Production

(2013) Alan Valaperti et al.   CIRCULATION

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

(2013) A. L. P. Caforio et al.   EUROPEAN HEART JOURNAL

Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives

(2012) Bernhard Maisch et al.   HEART FAILURE REVIEWS

Interferon-Beta Improves Survival in Enterovirus-Associated Cardiomyopathy

(2012) Uwe Kühl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The management of myocarditis

(2011) H.-P. Schultheiss et al.   EUROPEAN HEART JOURNAL

Chemokine control of West Nile virus infection

(2011) Jean K. Lim et al.   EXPERIMENTAL CELL RESEARCH

Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation

(2010) K. Allers et al.   BLOOD

A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy

(2010) Carlos Gorbea et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients

(2009) F. L.H. Muntinghe et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation

(2009) Gero Hütter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Myocarditis

(2009) Leslie T. Cooper   NEW ENGLAND JOURNAL OF MEDICINE

Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis

(2009) Manuela Rossol et al.   ARTHRITIS RESEARCH & THERAPY

Chemokines in Vascular Dysfunction and Remodeling

(2008) Andreas Schober   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Common CCR5-del32 Frameshift Mutation Associated With Serum Levels of Inflammatory Markers and Cardiovascular Disease Risk in the Bruneck Population

(2008) Ali R. Afzal et al.   STROKE